(MENAFN- EIN Presswire) EINPresswire/ -- "The chromosomal microarray reflex testing market is witnessing significant growth as advancements in genetic diagnostics continue to transform healthcare.

This initiative supports Astra Biotech’s aim of facilitating early diagnosis of individuals’ risk factors through innovative assays. In this way long-term effects of a disease can be minimised and ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

Affymetrix Inc. announced that the US Food and Drug Administration (FDA) has granted regulatory clearance to its GCS3000Dx (GCSDx) platform for in vitro gene expression diagnostic testing. The ...

Farmington, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The Global Microarrays Market size was estimated at USD 3.72 Billion in 2022 and is expected to surpass USD 8.15 Billion by 2030, expanding at a CAGR of 8 ...

Researchers at the University of Nottingham have developed a new genetic test that can diagnose brain tumours in as little as 2 hours. The test, called ROBIN, uses PromethION nanopore sequencing to ...

NEW YORK--(BUSINESS WIRE)--Nucleus Genomics, a next-generation consumer genetic testing and analysis company, has raised $14 million in a new funding round led by Alexis Ohanian's Seven Seven Six. The ...